Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Thaker

Showing results (141-150 of 237) with videos related to

Pageof 24
Sort By:
Gynecologic Oncology|September 3, 2021
Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancerKatherine C Fuh, Michael A Bookman, Joyce F Liu, et al.
Gynecologic Oncology|March 12, 2013
Low yield of residual vulvar carcinoma and dysplasia upon re-excision for close or positive marginsYevgeniya J Ioffe, Britt K Erickson, Katelyn E Foster, et al.
Gynecologic Oncology|May 10, 2022
Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomographyTyler R Mckinnish, Molly M Greenwade, Ivy Wilkinson-Ryan, et al.
Gynecologic Oncology|August 14, 2017
A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group studyPremal H Thaker, William E Brady, Heather A Lankes, et al.
International Journal of Radiation Oncology, Biology, Physics|November 17, 2018
Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix CancerAlexander J Lin, Elizabeth Kidd, Farrokh Dehdashti, et al.
Obstetrics and Gynecology|June 9, 2017
Wound Complication Rates After Staples or Suture for Midline Vertical Skin Closure in Obese Women: A Randomized Controlled TrialLindsay M Kuroki, Mary M Mullen, L Stewart Massad, et al.
Gynecologic Oncology|September 17, 2017
Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancerPratibha S Binder, Lindsay M Kuroki, Peinan Zhao, et al.
Scientific Reports|September 23, 2022
Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopyXiandong Leng, Sitai Kou, Yixiao Lin, et al.
Gynecologic Oncology|December 14, 2011
A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group studyNatalie Gould, Michael W Sill, Robert S Mannel, et al.
Brain, Behavior, and Immunity|December 11, 2023
The biology of hope: Inflammatory and neuroendocrine profiles in ovarian cancer patientsSusan K Lutgendorf, Rachel M Telles, Brendan Whitney, et al.
Pageof 24

Showing results (141-150 of 237) with videos related to

Sort By:
Pageof 24
Gynecologic Oncology|September 3, 2021
Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancerKatherine C Fuh, Michael A Bookman, Joyce F Liu, et al.
Gynecologic Oncology|March 12, 2013
Low yield of residual vulvar carcinoma and dysplasia upon re-excision for close or positive marginsYevgeniya J Ioffe, Britt K Erickson, Katelyn E Foster, et al.
Gynecologic Oncology|May 10, 2022
Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomographyTyler R Mckinnish, Molly M Greenwade, Ivy Wilkinson-Ryan, et al.
Gynecologic Oncology|August 14, 2017
A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group studyPremal H Thaker, William E Brady, Heather A Lankes, et al.
International Journal of Radiation Oncology, Biology, Physics|November 17, 2018
Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix CancerAlexander J Lin, Elizabeth Kidd, Farrokh Dehdashti, et al.
Obstetrics and Gynecology|June 9, 2017
Wound Complication Rates After Staples or Suture for Midline Vertical Skin Closure in Obese Women: A Randomized Controlled TrialLindsay M Kuroki, Mary M Mullen, L Stewart Massad, et al.
Gynecologic Oncology|September 17, 2017
Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancerPratibha S Binder, Lindsay M Kuroki, Peinan Zhao, et al.
Scientific Reports|September 23, 2022
Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopyXiandong Leng, Sitai Kou, Yixiao Lin, et al.
Gynecologic Oncology|December 14, 2011
A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group studyNatalie Gould, Michael W Sill, Robert S Mannel, et al.
Brain, Behavior, and Immunity|December 11, 2023
The biology of hope: Inflammatory and neuroendocrine profiles in ovarian cancer patientsSusan K Lutgendorf, Rachel M Telles, Brendan Whitney, et al.
Pageof 24